Senseonics Announces the First Pediatric Study Participant Insertions in the ENHANCE Clinical Trial

GERMANTOWN, Md.–(BUSINESS WIRE)–Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced the first pediatric study participant has been inserted with Eversense® 365-day system as part of the pivotal ENHANCE clinical trial at the AMCR Institute, … [Read more…]

MHN, Partners Launch Nation’s Most Comprehensive Healthy Food Delivery Study Among Medicaid Recipients

Data-driven, culturally informed, educational approach aims to reduce chronic disease burden and food insecurity in Chicago CHICAGO–(BUSINESS WIRE)–The first Chicagoan received a box of fresh produce March 20, 2023 as part of a pilot produce prescription program run by a partnership between Medical Home Network (MHN), Top Box Foods and Alivio Medical Center (AMC). The … [Read more…]

Exai Bio Presents New Non-Small Cell Lung Cancer Early Detection Data at the American Association for Cancer Research (AACR) 2023 Annual Meeting

Findings demonstrate highly sensitive and specific detection of the earliest and smallest tumors using Exai’s novel RNA- and AI-based liquid biopsy platform PALO ALTO, Calif.–(BUSINESS WIRE)–Exai Bio today announced new data demonstrating that its novel RNA- and AI-based platform detected non-small cell lung cancer with high accuracy, at the earliest stages and for the smallest … [Read more…]

Palleon Pharmaceuticals Presents Initial Phase 1 Results from the GLIMMER-01 Clinical Trial for E-602, the First Ever Glyco-Immune Checkpoint Inhibitor

– Proof of mechanism for novel glyco-immune checkpoint inhibitor established with evidence of dose dependent desialylation and immune system activation – – E-602 was well-tolerated across the entire dose range with no dose-limiting toxicities – – Palleon to proceed with Phase 2 evaluation – WALTHAM, Mass.–(BUSINESS WIRE)–Palleon Pharmaceuticals, a clinical-stage company pioneering glyco-immunology drug development … [Read more…]

Netsmart Demonstrates Person-Centered Interoperability Innovation at HIMSS 2023

OVERLAND PARK, Kan.–(BUSINESS WIRE)–#AI—Netsmart, a healthcare technology provider for the human services and post-acute care communities, will showcase its innovative connectivity and interoperability solutions at the HIMSS Global Health Conference & Exhibition 2023 (HIMSS) event on April 17-21 in Chicago. As a founding member of the Carequality network, Netsmart has been a longtime advocate for … [Read more…]

Foothold Technology Expands Their Partners with Their First All-Children Health Home; The Collaborative for Children and Families, Inc. (CCF)

NEW YORK–(BUSINESS WIRE)–Foothold Technology (Foothold), a company that supports more than 1,000 human services agencies across 29 states with its leading Care Coordination and Electronic Health Record (EHR) system, announced its partnership with their first all-children’s health home, The Collaborative for Children and Families, Inc. (CCF), a Health Home Serving Children and Families designated by … [Read more…]

AHF Applauds Ghana for Approving Malaria Vaccine, Urges WHO Approval after Trials

LOS ANGELES–(BUSINESS WIRE)–#Africa–As Ghana becomes the first country in Africa and globally to approve the University of Oxford’s new malaria vaccine for young children, AIDS Healthcare Foundation (AHF) commends Ghana for its decision and urges the World Health Organization (WHO) to approve the vaccine quickly if current late-stage trials are successful. “This is a big … [Read more…]

More Than 150 Million Americans Now Have Insurance Coverage for Kerecis’ Medical-Fish-Skin Wound Treatment

REYKJAVIK, Iceland & ARLINGTON, Va.–(BUSINESS WIRE)–#fishskin–Kerecis announced today that, over the past year, 63 million more Americans became eligible for insurance coverage for the company’s fish-skin treatments, an increase of more than 70%. This is the result of more private insurance companies deciding to cover the Kerecis fish-skin technology, in addition to previously existing Medicare … [Read more…]

Mythic Therapeutics Presents Preclinical Data on Investigational cMET-Targeting Antibody-Drug Conjugate (ADC) MYTX-011 at American Association for Cancer Research (AACR) Annual Meeting

Data demonstrate higher internalization in cMET positive (cMET+) tumor cells and broader, more potent efficacy, including a greater than 3-fold increase in efficacy in mouse models of non-small cell lung cancer (NSCLC), as compared to other cMET-targeting ADCs Data establish preclinical proof of concept for MYTX-011 in the treatment of a broader cMET+ patient population, … [Read more…]

BMI is out. BFI is in. Why BodySpec created a better way to measure your health.

It’s no secret that BMI is a flawed metric for measuring our health. It’s why BodySpec developed a new metric they’ve coined “BFI” that incorporates more than just weight and height, using hundreds of thousands of data points from their body composition scans. AUSTIN, Texas–(BUSINESS WIRE)–BMI is widely accepted as a flawed metric for our … [Read more…]